People with Obesity are at risk of developing certain Cancers

Original Article: https://www.medscape.com/viewarticle/obesity-and-cancer-untangling-complex-web-2024a10009zi

The Connection Between Obesity and Cancer 

Obesity is linked to an increased risk of developing many types of cancer. Scientists have found that excess body weight can trigger changes in the body that promote cancer growth. These … [Read More]

AI Predicts Diabetes Risk Successfully

Original Article: https://www.medscape.com/viewarticle/artificial-intelligence-model-successfully-assesses-t2d-risk-2024a1000asw

A new research study looking at whether AI can predict type 2 diabetes (T2D)

Researchers developed a new type of artificial intelligence (AI) model to see whether a computer can predict the risk of T2D. This model … [Read More]

​​Expert Group Reviews Evidence for Diabetes Devices

Original Article: https://www.medtechdive.com/news/medcac-medicare-advisory-panel-diabetes-device-evidence/716869

What are the Benefits of New Technologies for Diabetes?

In the United States, the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) recently assessed the effectiveness of advanced diabetes devices. These technologies include continuous glucose monitors and … [Read More]

Revisiting the Risks of Weight Loss Drugs for Stomach Issues

Original Article: https://www.medscape.com/viewarticle/gi-complications-glp-1s-weight-loss-reexamining-risks-2024a10009qf

Weight Loss Medicines and Stomach Problems

A recent study looked into the possible link between certain weight loss medications called GLP-1 receptor agonists and stomach upsets. These drugs are known for helping people lose weight, but there … [Read More]

Semaglutide Shows Promise in Treating Kidney Disease due to diabetes

Original Article: https://www.medscape.com/viewarticle/semaglutide-significantly-improves-chronic-kidney-disease-2024a10009w9

New Hope for Kidney Health

Semaglutide, a medication primarily used to treat type 2 diabetes, has shown significant promise in improving chronic kidney disease, which is a common and serious complication associated with diabetes. In a recent … [Read More]

Parents’ Views on their Childrens’ Diets

Original Article: https://thehill.com/changing-america/well-being/longevity/4616139-most-parents-dont-think-standard-american-diet-is-healthy-for-children

Concerns About the Standard American Diet

A recent poll by the University of Michigan’s C.S. Mott Children’s Hospital has revealed that most parents don’t consider the typical American diet healthy for children. This diet often contains high … [Read More]

Effective Therapies for Digestive Disorders

Original Article: https://www.medscape.com/viewarticle/psychological-approaches-calm-functional-digestive-disorders-2024a10007na

Exploring Alternative Treatments

At a recent medical conference, experts discussed new ways to manage symptoms of functional digestive disorders such as irritable bowel syndrome (IBS). Traditional medications are often not completely effective or their benefit runs out. … [Read More]

Daye’s Diagnostic Tampon: A Breakthrough in Vaginal Health Screening

Original Article: https://www.med-technews.com/news/latest-medtech-news/%E2%80%98world-first%E2%80%99-tampon-based-at-home-vaginal-health-screening-kit-now-available-at-boots

Redefining Vaginal Health Screening

Daye, a startup focusing on women’s health, has introduced a groundbreaking product: the Diagnostic Tampon. This tampon, available in the UK, isn’t just for periods anymore. It’s designed as a simple and convenient … [Read More]

FDA Approves New Antibiotic for UTIs

Original Article: https://www.medscape.com/viewarticle/fda-approves-new-antibiotic-uncomplicated-utis-2024a100087g?ecd=WNL_trdalrt_pos1_240427_etid6474654&uac=476612SY&impID=6474654

Introduction to Pivmecillinam

The US FDA has given the green light to a new antibiotic called pivmecillinam for treating uncomplicated urinary tract infections (UTIs) in women aged 18 and above. This drug, marketed as Pivya, has been … [Read More]